Ima-Go
Financiado
A High throughput Functional Imaging Platform to Accelerate Drug Discovery
The aim of this SME Instruments Phase 1 proposal is to perform a feasibility study for the commercialization of Ima-Go, a novel 96-well functional imaging platform for preclinical drug discovery for substances targeting brain dise...
The aim of this SME Instruments Phase 1 proposal is to perform a feasibility study for the commercialization of Ima-Go, a novel 96-well functional imaging platform for preclinical drug discovery for substances targeting brain diseases.
In contrast to state-of-the-art technologies for functional imaging, which either interfere with cellular viability and physiology or provide only a poor spatiotemporal resolution, Ima-Go is label-free, non-invasive and provides readouts of highest quality and resolution. The Ima-Go platform will introduce to the market new biological assays for human cell lines, which cannot be performed by current competing technologies.
MaxWell Biosystems AG developed the most advanced functional imaging platform for tracking neuronal activity used in basic neuroscience research. With Ima-Go, MaxWell Biosystem will scale this technology to a throughput required in drug discovery applications. MaxWell Biosystems AG aims to become a world-wide technology leader in the field of advanced functional imaging platforms and modern data analysis solutions, meeting the needs of pharmaceutical companies and contract research organizations to accelerate drug development.
ver más
Duración del proyecto: 6 meses
Fecha Inicio: 2019-01-28
Fecha Fin: 2019-07-31
Fecha Fin: 2019-07-31
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2019-07-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
MAXWELL BIOSYSTEMS AG
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
757.44K€ |
Participante